Peripheral and spinal 5-HT receptors participate in the pronociceptive and antinociceptive effects of fluoxetine in rats

Neuroscience

Volumn 252, Issue , 2013, Pages 396-409

  Cervantes Duran C ^a   Rocha Gonzalez H I ^b   Granados Soto, V ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

5 HT receptors; Fluoxetine; Formalin test; Mechanism of action; Nociception

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2,3,6,7 TETRAHYDRO 1' METHYL 5 [[2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL) 4 BIPHENYLYL]CARBONYL]SPIRO[FURO[2,3 F]INDOLE 3,4' PIPERIDINE]; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 3 [4 (3 CHLOROPHENYL) 1 PIPERAZINYL] 1,1 DIPHENYL 2 PROPANOL; 4 IODO N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL]BENZENE SULFONAMIDE; 8 [5 [2,4 DIMETHOXY 5 (4 TRIFLUOROMETHYLPHENYLSULFONAMIDO)PHENYL] 5 OXOPENTYL] 1,3,8 TRIAZASPIRO[4.5]DECANE 2,4 DIONE; [[3 [2 [4 (4 FLUOROBENZOYL) 1 PIPERIDINYL]ETHYL] 2,4 (1H,3H)QUINAZOLINEDIONE TARTRATE]]; FLUOXETINE; FORMALDEHYDE; KETANSERIN; N [2 (DIMETHYLAMINO)ETHYL]N [[4' [[(2 PHENYLETHYL)AMINO]METHYL](1,1'BIPHENYL) 4 YL]METHYL]CYCLOPENTANEPROPANAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; ONDANSETRON; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 5A RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM SENSITIZATION; FEMALE; FETUS; HYPERALGESIA; INFLAMMATION; LICKING; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONIN UPTAKE; SPINAL CORD DORSAL HORN;

3-(2-[4-(4-FLUOROBENZOYL)-1-PIPERIDINYL]ETHYL)-2,4(1H,3H)-QUINAZOLINEDIONE(+)TARTRATE; (N-[2-(DIMETHYLAMINO)ETHYL]-N-[[4′-[[(2-PHENYLETHYL)AMINO]METHYL][1,1′-BIPHENYL]-4-YL]METHYL]CYCLOPENTANEPROPANAMIDE DIHYDROCHLORIDE; (R)-3-(2-(2-(4-METHYLPIPERIDIN-1-YL)ETHYL)PYRROLIDINE-1-SULFONYL)PHENOL HYDROCHLORIDE; 1′-METHYL-5-[[2′-METHYL-4′-(5-METHYL-1,2,4-OXADIAZOL-3-YL)BIPHENYL-4-YL]CARBONYL]-2,3,6,7-TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4′-PIPERIDINE HYDROCHLORIDE; 4-(3-CHLOROPHENYL)-Α-(DIPHENYLMETHYL)-1-PIPERAZINEETHANOL HYDROCHLORIDE; 4-IODO-N-[4-METHOXY-3-(4-METHYL-1-PIPERAZINYL)PHENYL]BENZENE-SULFONAMIDE HYDROCHLORIDE; 5-HT; 5-HT RECEPTORS; 5-HYDROXYTRYPTAMINE; 8-[5-(2,4-DIMETHOXY-5-(4-TRIFLUOROMETHYLPHENYLSULPHONAMIDO)PHENYL-5-OXOPENTYL]1,3,8-TRIAZASPIRO[4.5] DECANE-2,4-DIONE HYDROCHLORIDE; ANOVA; AREA UNDER THE NUMBER OF FLINCHES AGAINST TIME CURVES; AUC; BRL-15572; DORSAL ROOT GANGLION; DRG; FLUOXETINE; FORMALIN TEST; GR-113808; GR-127935; MECHANISM OF ACTION; N-[2-[4-(2-METHOXYPHENYL)-1-PIPERAZINYL]ETHYL]-N-2-PYRIDINYLCYCLOHEXANECARBOXAMIDE MALEATE; N-[4-METHOXY-3-(4-METHYL-1-PIPERAZINYL)PHENYL]-2′-METHYL-4′-(5-METHYL-1,2,4-OXADIAZOL-3-YL)-1,1′-BIPHENYL-4-CARBOXAMIDE HYDROCHLORIDE HYDRATE; NOCICEPTION; ONE-WAY ANALYSIS OF VARIANCE; RS-102221; RS-127445; SB-224289; SB-258585; SB-269970; SB-699551; SELECTIVE SEROTONIN REUPTAKE INHIBITORS; SSRIS; WAY-100635; [1-[2-METHYLSULPHONYLAMINO ETHYL]-4-PIPERIDINYL]METHYL 1-METHYL-1H-INDOLE-3-CARBOXYLATE;

ANIMALS; FEMALE; FLUOXETINE; PAIN; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SPINAL CORD;

EID: 84884541301     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.022     Document Type: Article

References (94)

1. Abbott F.V., Franklin K.B., Westbrook R.F. The formalin test: scoring properties of the first and second phases of the pain response in rats. Pain 1995, 60:91-102.
2. 3 in nociceptive processing in the rat spinal cord: results from behavioural and electrophysiological studies. Neurosci Lett 1996, 208:203-207.
3. Ambriz-Tututi M., Cruz S.L., Urquiza-Marín H., Granados-Soto V. Formalin-induced long-term secondary allodynia and hyperalgesia are maintained by descending facilitation. Pharmacol Biochem Behav 2011, 98:417-424.
4. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
5. 1B/D autoreceptors. Synapse 1999, 31:13-19.
6. Basbaum A.I., Fields H.L. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 1978, 4:451-462.
7. Bee L.A., Dickenson A.H. Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states. Neuroscience 2007, 147:786-793.
8. Beyer C.E., Cremers T.I. Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin?. Eur J Pharmacol 2008, 580:350-354.
9. Bianchi M., Moser C., Lazzarini C., Vecchiato E., Crespi F. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes. Exp Brain Res 2002, 143:191-197.
10. 2B receptor antagonist. Br J Pharmacol 1999, 127:1075-1082.
11. 2C receptor antagonist. Neuropharmacology 1997, 36:621-629.
12. 7 receptors. J Neurochem 2009, 108:1126-1135.
13. 3 receptors in development and maintenance of formalin-induced long-term secondary allodynia and hyperalgesia. Pharmacol Biochem Behav 2012, 101:246-257.
14. Braz J.M., Basbaum A.I. Genetically expressed transneuronal tracer reveals direct and indirect serotonergic descending control circuits. J Comp Neurol 2008, 507:1990-2003.
15. 7 receptors in the modulation of pain under sensitizing conditions. Eur J Pain 2012, 16:72-81.
16. 3 receptors. Br J Pharmacol 1988, 94:397-412.
17. 6 receptors according to the rat formalin test. Neuroscience 2009, 162:444-452.
18. 2B receptors in formalin-induced nociception. Pharmacol Biochem Behav 2012, 102:30-35.
19. Chen J.J., Vasko M.R., Wu X., Staeva T.P., Baez M., Zgombick J.M., Nelson D.L. Multiple subtypes of serotonin receptors are expressed in rat sensory neurons in culture. J Pharmacol Exp Ther 1998, 287:1119-1127.
20. Crowell M.D., Jones M.P., Harris L.A., Dineen T.N., Schettler V.A., Olden K.W. Antidepressants in the treatment of irritable bowel pain syndromes. Curr Opin Invest Drugs 2004, 5:736-742.
21. Doak G.J., Sawynok J. Formalin-induced nociceptive behavior and edema: involvement of multiple peripheral 5-hydroxytryptamine receptor subtypes. Neuroscience 1997, 80:939-949.
22. 5A receptor localization in the rat spinal cord suggests a role in nociception and control of pelvic floor musculature. J Comp Neurol 2004, 476:316-329.
23. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977, 4:161-174.
24. 1A receptor antagonist, WAY-100635. Eur J Pharmacol 1995, 281:81-88.
25. o proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol 1998, 361:299-309.
26. Fu K.Y., Light A.R., Maixner W. Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw. J Pain 2001, 2:2-11.
27. 4 receptor. Br J Pharmacol 1994, 111:332-338.
28. 1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro-spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo. J Med Chem 1998, 41:1218-1235.
29. Godefroy F., Weil-Fugazza J., Besson J.M. Complex temporal changes in 5-hydroxytryptamine synthesis in the central nervous system induced by experimental polyarthritis in the rat. Pain 1987, 28:223-238.
30. 7 receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia. Pain 2011, 152:687-697.
31. 3 receptors in the anaesthetized rat. Pain 2000, 89:81-88.
32. 1B receptors causes hypothermia in the guinea pig. Eur J Pharmacol 1997, 331:169-174.
33. Heinricher M.M., Tavares I., Leith J.L., Lumb B.M. Descending control of nociception: specificity, recruitment and plasticity. Brain Res Rev 2009, 60:214-225.
34. 6 receptors in rat, pig and human brain tissue. Br J Pharmacol 2000, 130:1597-1605.
35. 1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur J Pharmacol 1994, 260:251-255.
36. Jeong C.Y., Choi J.I., Yoon M.H. Roles of serotonin receptor subtypes for the antinociception of 5-HT in the spinal cord of rats. Eur J Pharmacol 2004, 502:205-211.
37. 1 receptor subtypes in the modulation of pain and synaptic transmission in rat spinal superficial dorsal horn. Br J Pharmacol 2012, 165:1956-1965.
38. Kayser V, Elfassi IE, Aubel B, Melfort M, Julius D, Gingrich JA, Hamon M, Bourgoin S (2007) Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice. 130:235-348.
39. 2A/2C receptors augments nociceptive responses in the rat. Brain Res 2001, 910:179-181.
40. 2C receptors. Naunyn Schmiedebergs Arch Pharmacol 2004, 370:114-123.
41. LaBuda C.J., Little P.J. Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 2005, 144:175-181.
42. 3H]WAY 100635 in the mouse. Eur J Pharmacol 1994, 271:505-514.
43. Leem J.W., Willis W.D., Chung J.M. Cutaneous sensory receptors in the rat foot. J Neurophysiol 1993, 69:1684-1699.
44. Leventhal L., Smith V., Hornby G., Andree T.H., Brandt M.R., Rogers K.E. Differential and synergistic effects of selective norepinephrine and serotonin reuptake inhibitors in rodent models of pain. J Pharmacol Exp Ther 2007, 320:1178-1185.
45. 2B mediates serotonin-induced mechanical hyperalgesia. J Neurosci 2011, 31:1410-1418.
46. Liu F.Y., Xing G.G., Qu X.X., Xu I.S., Han J.S., Wan Y. Roles of 5-hydroxytryptamine (5-HT) receptor subtypes in the inhibitory effects of 5-HT on C-fiber responses of spinal wide dynamic range neurons in rats. J Pharmacol Exp Ther 2007, 321:1046-1053.
47. Liu X.Y., Wu S.X., Wang Y.Y., Wang W., Zhou L., Li Y.Q. Changes of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by bee venom-induced inflammatory pain. Neurosci Lett 2005, 375:42-46.
48. LoPachin R.M., Rudy T.A., Yaksh T.L. An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav 1981, 27:559-561.
49. 2 in the spinal cord. Pain 2012, 153:86-94.
50. Mercado C.P., Kilic F. Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Mol Interv 2010, 10:231-241.
51. Millan M.J. Descending control of pain. Prog Neurobiol 2002, 66:355-474.
52. 1B receptors in spinal nociceptive transmission and in the modulation of NMDA induced behaviour. Neuroreport 1992, 3:1061-1064.
53. Nagayasu K., Yatani Y., Kitaichi M., Kitagawa Y., Shirakawa H., Nakagawa T., Kaneko S. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release. Br J Pharmacol 2010, 161:1527-1541.
54. Nakajima K., Obata H., Ito N., Goto F., Saito S. The nociceptive mechanism of 5-hydroxytryptamine released into the peripheral tissue in acute inflammatory pain in rats. Eur J Pain 2009, 13:441-447.
55. Nayebi A.R., Hassanpour M., Rezazadeh H. Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioural response in the formalin test in rats. J Pharm Pharmacol 2001, 53:219-225.
56. Nikai T., Basbaum A.I., Ahn A.H. Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain 2008, 139:533-540.
57. Obata H., Saito S., Ishizaki K., Goto F. Antinociception in rat by sarpogrelate, a selective 5-HT2A receptor antagonist, is peripheral. Eur J Pharmacol 2000, 404:95-102.
58. O'Connell P.J., Wang X., Leon-Ponte M., Griffiths C., Pingle S.C., Ahern G.P. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 2006, 107:1010-1017.
59. Owens M.J., Morgan W.N., Plott S.J., Nemeroff C.B. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 1997, 283:1305-1322.
60. Oyama T., Ueda M., Kuraishi Y., Akaike A., Satoh M. Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neurosci Res 1996, 25:129-135.
61. Pedersen L.H., Nielsen A.N., Blackburn-Munro G. Anti-nociception is selectively enhanced by parallel inhibition of multiple subtypes of monoamine transporters in rat models of persistent and neuropathic pain. Psychopharmacology 2005, 182:551-561.
62. Parada C.A., Tambeli C.H., Cunha F.Q., Ferreira S.H. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 2001, 102:937-944.
63. Pierce P.A., Xie G.X., Levine J.D., Peroutka S.J. 5-Hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: a polymerase chain reaction study. Neuroscience 1996, 70:553-559.
64. 1D receptors. Naunyn Schmiedebergs Arch Pharmacol 1997, 356:312-320.
65. 7 receptors in the formalin test. Pain 2005, 117:182-192.
66. 3 receptors on the modulation of nociceptive transmission in rat spinal cord according to the formalin test. Eur J Pharmacol 2001, 424:45-52.
67. Sawynok J., Esser M.J., Reid A.R. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 1999, 82:149-158.
68. Sawynok J., Reid A. Lesions to ascending noradrenergic and serotonergic pathways modify antinociception produced by intracerebroventricular administration of morphine. Neuropharmacology 1989, 28:141-147.
69. Sawynok J., Reid A. Antinociception by tricyclic antidepressants in the rat formalin test: differential effects on different behaviours following systemic and spinal administration. Pain 2001, 93:51-59.
70. 1B receptor antagonist with negative intrinsic activity. Br J Pharmacol 1998, 125:202-208.
71. Sikka P., Kaushik S., Kumar G., Kapoor S., Bindra V.K., Saxena K.K. Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice. J Pharm Bioallied Sci 2011, 3:412-416.
72. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999, 83:389-400.
73. Singh V.P., Jain N.K., Kulkarni S.K. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res 2001, 915:218-226.
74. 1D receptor antagonist GR 127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropsychopharmacology 1995, 34:377-382.
75. Sommer C. Is serotonin hyperalgesic or analgesic?. Curr Pain Headache Rep 2006, 10:101-106.
76. Sufka K.J., Schomburg F.M., Giordano J. Receptor mediation of 5-HT-induced inflammation and nociception in rats. Pharmacol Biochem Behav 1992, 41:53-56.
77. Suzuki R., Rygh L.J., Dickenson A.H. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 2004, 25:613-617.
78. Svensson C.I., Tran T.K., Fitzsimmons B., Yaksh T.L., Hua X.Y. Descending serotonergic facilitation of spinal ERK activation and pain behavior. FEBS Lett 2006, 580:6629-6634.
79. Tatsumi M., Groshan K., Blakely R.D., Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997, 340:249-258.
80. Thomas D.R., Atkinson P.J., Ho M., Bromidge S.M., Lovell P.J., Villani A.J., Hagan J.J., Middlemiss D.N., Price G.W. 3H-SB-269970-A selective antagonist radioligand for 5-HT7 receptors. Br J Pharmacol 2000, 130:409-417.
81. 5A receptor in guinea pig brain. Neuropharmacology 2006, 51:566-577.
82. 2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain 1998, 76:349-355.
83. - cotransporter in the development of capsaicin-induced neurogenic inflammation. J Neurophysiol 2006, 95:3553-3561.
84. Vega E., Rudolph M.I. Characterization of oxytocin receptors and serotonin transporters in mast cells. Endocrine 2002, 18:167-172.
85. 4 receptors in the human and guinea-pig brain. Neuroreport 1993, 4:1239-1242.
86. Wei F., Dubner R., Zou S., Ren K., Bai G., Wei D., Guo W. Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci 2010, 30:8624-8636.
87. Weihe E., Eiden L.E. Chemical neuroanatomy of the vesicular amine transporters. FASEB J 2000, 14:2435-2449.
88. Wheeler-Aceto H., Porreca F., Cowan A. The rat paw formalin test: comparison of noxious agents. Pain 1990, 40:229-238.
89. Wu S., Zhu M., Wang W., Wang Y., Li Y., Yew D.T. Changes of the expression of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by complete Freund's adjuvant-induced inflammation. Neurosci Lett 2001, 307:183-186.
90. Yaksh T.L., Wilson P.R. Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther 1979, 208:446-453.
91. 3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors. J Neurosci 2002, 22:1010-1019.
92. 1B receptors in modulating spinal nociceptive transmission in normal and carrageenan-injected rats. Pain 2001, 92:201-211.
93. Zhao Z.Q., Chiechio S., Sun Y.G., Zhang K.H., Zhao C.S., Scott M., Johnson R.L., Deneris E.S., Renner K.J., Gereau R.W., Chen Z.F. Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci 2007, 27:6045-6053.
94. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.